INNPF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Innocan Pharma Corp

Watchlist Manager

Watchlist

Price: 1.33 USD -5%

Market Cap: $373.3m

	Innocan Pharma Corp OTC:INNPF	IL
	Fortuna Metals Ltd ASX:FUN	AU
I	Incross Co Ltd KOSDAQ:216050	KR
	Phoenix New Media Ltd F:1PX	CN
A	Agrieuro Corp OTC:EURI	RO
P	Pan Malaysia Corporation Bhd KLSE:PMCORP	MY

Profitability Summary

Innocan Pharma Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

89%

Declining Gross Margin

94% > 90%

Negative Operating Margin

-15%

Negative 3Y Average Operating Margin

-9%

Operating Margin is Increasing

-44% > -15%

Negative Net Margin

-4%

Negative 3Y Average Net Margin

-12%

Net Margin is Increasing

-51% > -4%

Negative Free Cash Flow Margin

-7%

Negative 3Y Average Free Cash Flow Margin

-7%

Free Cash Flow Margin is Increasing

-40% > -7%

Negative ROE

-21%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-38%

ROIC is Increasing

-202% > -91%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.